A new review charts how stem cell transplantation, lentiviral gene therapy, and CRISPR-based editing such as Casgevy are ...

The presentation, titled "First-in-human evidence of RNA activation-mediated sarcolemmal utrophin upregulation in Duchenne ...

A team of bioengineers in Barcelona has built a standardized genetic toolkit that turns the harmless soil bacterium Bacillus subtilis into a miniature factory for protein-glutamine glutaminase, an ...

Regeneron has been enrolling a dedicated LGSOC cohort at this dose and will advance ubamatamab into a confirmatory Phase 3 trial of this lethal cancer with limited treatment optio ...

One of the strongest signals, albeit weaker than the original GWAS findings two decades ago, highlighted a novel regulatory ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced a Start-Up Agreement with Mass ...

Target clinical and biopharma segments, forge strategic partnerships, and differentiate with scalable, low-toxicity delivery solutions.Dublin, Sept. (GLOBE NEWSWIRE) -- "North America Non-Viral ...

Capitalize on gene therapy and vaccine demand through automated, scalable DNA synthesis and actionable segment, regional, and competitive insights.Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "DNA ...

“It should be protocol that 100% of your patients with metastatic prostate cancer get germline testing. Full stop. No exceptions,” said Neal D. Shore, MD, FACS.

CAR T-cell therapy produced a 68% overall response rate in 194 patients with PCNSL, but progression-free survival fell to 25% ...

I have completed a master's degree in a science graduate program and work as a researcher at a manufacturing company. At ...

Uncover the fascinating science of extremophiles, life flourishing in Earth's harshest environments. Learn how these remarkable organisms adapt to extreme ...